Skip to content

Dr. Kevin Maas

Active
Private limited companyfounded 20233 yrs activeSteenkuilstraat(M) 116, 3630 Maasmechelen, BelgiumKBO/BCE: BE 0801.181.990

Dr. Kevin Maas has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €137k and a net result of €48k. Its solvency ranks better than 60% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
95 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency97=
Growth52
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity ample (current ratio 3.55 against 3.35 in 2024; short-term debt: 27.4% and cash: 69.5% of total assets), and 27.5% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
72.5%
Return on assets
25.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
on the day
2024
1 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€137k▲ 53.2%
2024 · €89k
2024: €89k
2024 → 2025
Total assets
€189k▲ 51.8%
2024 · €124k
2024: €124k
2024 → 2025
Net result
€48k▼ 44.5%
2024 · €87k
2024: €87k
2024 → 2025
Working capital
€132k▲ 60.4%
2024 · €82k
2024: €82k
2024 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20242025Trend
Equity€89k-€137k▲ 53.2%
Operating result€117k-€68k▼ 41.8%
Net result€87k-€48k▼ 44.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2024: €117k€117kNet result 2024: €87k€87kOperating result 2025: €68k€68kNet result 2025: €48k€48k20242025
The operating result falls in 2025; 2025 is 42% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €189k
Fixed assets €5k▼ 27.0%
Current assets €184k▲ 56.6%
Equity and liabilities €189k
Equity €137k▲ 53.2%
Debt €52k▲ 48.3%
The debt ratio falls from 28.2% to 27.5%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€70k
2024 · €118k
Cash flow
€50k
2024 · €89k
Solvency
72.5%
2024 · 71.8%
Current ratio
3.55
2024 · 3.35
Quick ratio
3.55
2024 · 3.35
Debt / equity
0.38
2024 · 0.39
ROE
35.3%
2024 · 97.6%
ROA
25.6%
2024 · 70.1%
Interest coverage
16.37
2024 · 42.55
Debt
€52k
2024 · €35k
Debt ≤ 1 year
€52k
2024 · €35k
Income taxes
€15k
2024 · €27k
Staff costs
€15k
2024 · €250
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€124k€189k
Fixed assets21/28€7k€5k
Tangible fixed assets22/27€7k€5k
Furniture and vehicles24€7k€5k
Current assets29/58€117k€184k
Amounts receivable within one year40/41€7k€700
Trade receivables40€7k€700
Current investments50/53-€47k
Cash at bank and in hand54/58€109k€131k
Deferred charges and accrued income490/1€2k€4k
Equity and liabilities
Total equity and liabilities10/49€124k€189k
Equity10/15€89k€137k
Contributions10/11€3k€3k=
Profit (loss) carried forward14€86k€134k
Amounts payable17/49€35k€52k
Amounts payable within one year42/48€35k€52k
Trade debts44€4k€3k
Suppliers440/4€4k€3k
Taxes, remuneration and social security45€28k€45k
Taxes450/3€28k€43k
Remuneration and social security454/9-€2k
Other amounts payable47/48€3k€4k
Accrued charges and deferred income492/3-€237
Income statement Code20242025
Remuneration, social security and pensions62€250€15k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€2k
Other operating charges640/8€623€651
Gross operating margin9900€119k€85k
Operating profit (loss)9901€117k€68k
Financial income75/76B€16€0
Recurring financial income75€16€0
Financial charges65/66B€3k€4k
Recurring financial charges65€3k€4k
Profit (loss) for the period before taxes9903€114k€64k
Income taxes67/77€27k€15k
Profit (loss) for the period9904€87k€48k
Profit (loss) for the period to be appropriated9905€87k€48k
Appropriation of the result
Profit (loss) to be appropriated9906€87k€135k
Profit (loss) brought forward from the previous period14P-€86k
Profit to be distributed694/7€859€859=
Return on contributions (dividend)694€859€859=

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Equity above €100kEq €137k ▲53.2%
2 profitable years in a row build equity to €137k.
30-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Maasmechelen · 1 establishment unit since 2023
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Steenkuilstraat(M) 1163630 Maasmechelen
Ground area
438 m²
Building footprint
97 m²
Volume, LiDAR
602 m³
Parcel 73048C0565/00H000, Flanders · tallest building 9.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Kevin Maas
Steenkuilstraat(M) 116, 3630 MaasmechelenGeneral medical practice
since 20232.344.454.960
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
73048C0565/00H000 Flanders 438 m² 1 · 97 m² 9.4 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2025 · 1 entry · 1,464 EUR awarded · 1,464 EUR paid
Year Entries awardedpaid
2025 1 1,464 EUR1,464 EUR
Schemes
Individueel Maatwerk
1 entry · 1,464 EUR · 1,464 EUR paid · Departement Werk, Economie, Wetenschap, Innovatie en Sociale Economie

Similar companies · same sector, comparable size

Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,448 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded26-04-2023
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.